CLEARWATER, FL - February 24, 2025 (NEWMEDIAWIRE) - REMSleep Holdings, Inc. (OTC: RMSL) announces the launch of new updated website dedicated for the launch of the new FDA cleared Deltawave nasal pillows CPAP mask.  The Deltawave is available to the market through the website.  We project first orders can be processed and available for shipment in approximately three weeks.  We are setting up an assembly, packaging, and shipping center dedicated to REMSleep products. 

We have filed for the REMSleep Medicare number and expect to have REMSleep Medicare number in approximately 30 days. REMSleep has sent samples of The Deltawave mask to large distributors for their review.  We obviously cannot disclose these distributors at this time, but we are corresponding with these distributors and hope to have more information in the near future.  We can say we have had a very positive response from these distributors.  Deltawave offers a new level of treatment for sleep apnea that has not been available.  Distributors and health care professionals will love and appreciate the therapeutic value and benefits of Deltawave for their sleep apnea patients.  We will soon focus on bringing the second-generation Longevity CPAP mask to market.  REMSleep CPAP masks will bring unprecedented compliance to CPAP treatment.

About REMSleep Holdings, Inc.

REMSleep Holdings, Inc. is a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive sleep apnea patients. Our focus is primarily designing and manufacturing devices and products for the treatment of sleep apnea and other respiratory conditions. With over 30 years of collective experience in CPAP therapy, the REMSleep team has extensive knowledge and understanding of CPAP and the challenges of patient compliance. We diligently strive for our products to make a difference and improve the condition of those suffering from sleep apnea.

Forward-looking Statements

This press release may contain forward-looking statements regarding the Company. All statements, other than statements of historical fact included herein, are "forward-looking statements" including statements regarding the Company’s future prospects and risks in investing in Company’s common stock. These statements are based upon the Company's current expectations and speak only as of the date hereof. Financial performance in one period does not necessarily mean continued or better performance in the future. The Company's actual results in any endeavor may differ materially and adversely from those expressed in any forward-looking statements as a result of various factors and uncertainties, which factors or uncertainties may be beyond our ability to foresee or control. Other risk factors include the status of the Company's common stock as a "penny stock" and those risk factors stated in reports filed with the U.S. Securities and Exchange Commission or SEC on its EDGAR website (URL:www.sec.gov)

Contact:
Tom Wood
912-590-2001
twood@remsleep.com

View the original release on www.newmediawire.com

This press release is distributed by NewMediaWire. Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is REMSleep Prepares to Launch New FDA Cleared CPAP Pillows Mask to Market.